Deutsche Bank initiates coverage on OSI Pharmaceuticals (Nasdaq: OSIP) with a Hold. Price target $33.

Deutsche analyst says, "We believe ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE